Patents by Inventor Anandhi Ranganathan Johri

Anandhi Ranganathan Johri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof
    Publication number: 20110190312
    Abstract: The invention relates to a combination which comprises: (a) an epothilone; and (b) a protein tyrosine kinase inhibitor; and optionally (c) a derivative of rapamycin; for simultaneous, separate or sequential use, in particular, for the delay of progression or treatment of a proliferative disease, especially cancer.
    Type: Application
    Filed: April 13, 2011
    Publication date: August 4, 2011
    Inventors: Jerry Min-Jian Huang, Anandhi Ranganathan Johri, Ronald Richard Linnartz, Paul M.J. McSheehy
  • CORTICOSTEROIDS TO TREAT EPOTHILONE OR EPOTHILONE DERIVATIVE INDUCED DIARRHEA
    Publication number: 20100267682
    Abstract: Epothilone derivatives are co-administered with an antidiarrheal agent, e.g., a corticosteroid, or a glucocorticoid steroid in the treatment of a proliferative disease.
    Type: Application
    Filed: October 15, 2008
    Publication date: October 21, 2010
    Applicant: NOVARTIS AG
    Inventors: Anandhi Ranganathan Johri, Paul M.J. McSheehy, Dirk Weber
  • Epothilone Combinations
    Publication number: 20090041715
    Abstract: The invention relates to combinations of (a) an epothilone with (b) two or more other antineoplastic agents for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease.
    Type: Application
    Filed: July 25, 2005
    Publication date: February 12, 2009
    Applicant: NOVARTIS AG
    Inventors: Richard Paul Becker, Anandhi Ranganathan Johri, Paul M.J. McSheehy, Sara Zaknoen
  • Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof
    Publication number: 20080139587
    Abstract: The invention relates to a combination which comprises: (a) an epothilone; and (b) a protein tyrosine kinase inhibitor; and optionally (c) a derivative of rapamycin; for simultaneous, separate or sequential use, in particular, for the delay of progression or treatment of a proliferative disease, especially cancer.
    Type: Application
    Filed: November 28, 2005
    Publication date: June 12, 2008
    Applicant: Novartis Ag
    Inventors: Jerry Min-Jian Huang, Anandhi Ranganathan Johri, Ronald Richard Linnartz, Paul M.J. McSheehy